ECTS2014 Poster Presentations Osteoporosis: treatment (68 abstracts)
The effect of alendronate oral jelly in the treatment of osteoporosis in clinical settings
Nobukazu Okimoto 1 , Shinobu Arita 2 , Syojiro Akahoshi 2 , Toru Yoshioka 3 & Yoshifumi Fuse 3
1Okimoto Clinic, Hiroshima, Japan; 2Obase Hospial, Fukuoka, Japan; 3Sakamidorii Hospital, Hiroshima, Japan.
Alendronate is one of the most popular anti-resorptive drugs and widely used to treat osteoporotic patients in the world. In Japan, alendronate oral jelly (ALN-J) as a new formulation was launched in 2013. Dissolution test and bioequivalence study were performed between ALN-J and alendronate oral weekly tablet (ALN-T), and bioequivalence of both drugs was approved. Dosage and administration of ALN-J is the same as ALN-T. Moreover, ALN-J has special features of easy swallowing and obvious distinguishability compared with ALN-T. However, little is known about clinical evidence such as BMD, bone turnover marker, safety and adherence in the treatment with ALN-J. We conducted the present study to verify the efficacy and safety of ALN-J in the treatment of osteoporosis. A number of 32 patients were enrolled in the present study, and age, history of prevalent fractures, BMD, bone turnover marker and others were investigated. Baseline characteristics of the patients were as follows; mean (S.D.) of age (years) was 78.25 (6.58); radius BMD (g/cm2), 0.45 (0.07); TRACP5b (mU/dl), 497.42 (160.92); P1NP (μg/l), 64.90 (25.66) respectively. After treatment, mean change in TRACP5b decreased by 36.7% and P1NP decreased by 43.7% for 3 months. The effect of ALN-J for change in bone turnover marker was confirmed in the treatment of osteoporosis in brief duration.
Article tools
My recent searches
My recently viewed abstracts
Bone Abstracts
ISSN 2052-1219 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more